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ABSTRACT 
 
Exercise Training Regulation of Extracellular Matrix 
and Remodeling in the Aging Rat Heart. (May 2008) 
Hyo Bum Kwak, B.Ed., Seoul National University; 
M.Ed., Seoul National University; 
M.S., Texas A&M University 
Chair of Advisory Committee: Dr. John M. Lawler 
 
Aging is characterized by a progressive impairment of cardiac structure and 
function. The cardiac remodeling involves loss of cardiac myocytes, reactive 
hypertrophy of the remaining cells, and increased extracellular matrix (ECM) and 
fibrosis in the aging heart. In contrast, exercise training not only improves cardiac 
function, but also reduces the risk of heart disease. However, the ability of exercise 
training to modulate ECM and remodeling in the aging heart remains unknown. 
Therefore, the purpose of this study was to determine the effects of exercise training on 
ECM remodeling in the aging heart. We hypothesized that (1) exercise training would 
attenuate age-related changes in left ventricle morphology including extramyocyte space 
and collagen contents, and (2) exercise training would ameliorate age-induced changes 
in ECM-related factors including MMPs, TIMPs, TNF-α, TGF-β1, and α-SMA in the 
heart. Three and 31 month old Fischer 344 × Brown Norway F1 hybrid rats were 
assigned to four groups: young sedentary (YS), young exercise-trained (YE), old 
 iv
sedentary (OS), and old exercise-trained (OE). Exercise training groups walked briskly 
on a treadmill for 45 min/day (12˚ incline) at 20m/min (young) or 10 m/min (old), 5 
d/wk for 12 wk. We found that endurance exercise training might ameliorate the age-
induced increase in extramyocyte space and collagen contents of the left ventricle. 
Exercise training might protect against age-induced fibrosis by increasing MMP-2, 
MMP-14 in the soluble fraction and MMP-1, MMP-3, MMP-14 in the insoluble fraction 
of old rat hearts. Conversely, exercise training might reduce the fibrosis by decreasing 
TIMP-1 in the soluble fraction of old rat hearts. Further, exercise training reduced 
potential upstream pro-fibrotic mediators including TNF-α and TGF-β1 in the aging rat 
hearts. These results are the first to demonstrate that exercise training has a protective 
effect against age-induced extracellular collagen matrix remodeling in the aging heart, 
associated with increased MMP-1, -2, -3, -14 and decreased TIMP-1, TNF-α, and TGF-
β1.  
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CHAPTER I 
INTRODUCTION 
 
Aging is characterized by a progressive impairment of cardiac structure including 
increased fibrosis and reduced cardiomyocyte volume density (51), and cardiac function 
including stroke volume, ejection fraction, and cardiac output (51, 120). There is 
increasing evidence that impairment of cardiac function with aging is a result of 
structural remodeling (16, 51). Cardiac remodeling involves loss of cardiac myocytes, 
reactive hypertrophy of the remaining cells, and increased extracellular matrix (ECM) 
including collagens and fibrosis in the aging heart (120). Myocyte loss through apoptosis 
and necrosis increases with advancing age in the heart (61, 68).  Fibrosis with aging is 
very critical in impairing heart function. Progressive upregulation in fibrosis results in 
increased collagen accumulation, elevated internal work, heart stiffness and contributes 
to diastolic or systolic dysfunction and ventricular remodeling (127). However, the 
precise mechanisms that lead toward increased fibrosis in the aging heart remain poorly 
understood.     
In contrast, long-term endurance exercise training improves cardiovascular work 
capacity, protects stress proteins, and reduces cardiovascular disease risk (11). Despite 
the great importance of exercise training to attenuate aging-related alterations, the ability 
of exercise training to ameliorate ECM remodeling in the aging heart has not been 
evaluated. To date, only our lab has demonstrated protective effects of endurance  
____________ 
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exercise training against increased apoptosis and cardiac remodeling in the aging heart, 
including accumulation of extramyocyte space (68). However, no studies exist regarding 
exercise training regulation of ECM remodeling in the aging heart. Moreover, the 
mechanisms by which exercise training protects against age-induced ECM remodeling in 
the heart are completely unknown. 
Therefore, the objectives of this study were to (i) determine the morphological 
effects of treadmill exercise training on age-induced ECM remodeling in the aging left 
ventricle, (ii) identify regulatory mechanisms by which exercise training alters 
extracellular matrix turnover and remodeling in the aging left ventricle, and (iii) identify 
putative upstream mechanisms by which exercise training affects ECM remodeling in 
the aging left ventricle. To accomplish the above objectives, we hypothesized that (i) 
exercise training would attenuate age-related changes in left ventricle morphology by 
ameliorating increases in extramyocyte space and collagen contents, (ii) exercise training 
would attenuate age-induced increases in (a) key matrix metalloproteinases (MMPs: 
MMP-1, -2, -3, -9,-14) and (b) tissue inhibitors of metalloproteinases (TIMPs: TIMP-1, -
2, -3, -4) in the aging left ventricle, and (iii) exercise training would attenuate age-
induced increases in TNF-α, TGF-β, and myofibroblast (α-smooth muscle actin) in the 
aging left ventricle. 
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Cardiac extracellular matrix 
Myocardial tissue is composed of cardiac myocytes, nonmyocytes (e.g., 
fibroblasts, endothelial cells, vascular smooth muscle cells, etc), and extracellular matrix 
(ECM) proteins (8, 23). Myocardial ECM is essential for proper cardiac structural 
integrity and pump function (8, 30). The ECM i) provides a scaffold for myocytes, 
fibroblasts, and endothelial cells, and ii) transmits mechanical forces and signals to 
myocardial fibers (8). The ECM also provides mechanical stability, physical strength, 
stiffness, ductility, and energy absorption to tissues. The ECM is essential for efficient 
cardiac function via myocyte alignment, regulating blood flow during contraction, and 
compliance. Moreover, the ECM is an important mediator of growth-related factor and 
in modulating the cardiac phenotype during development and hypertrophy. Therefore, 
the disruption of ECM homeostasis is a key factor for the progression of cardiac 
dysfunction (8).  
The ECM in the heart is composed of collagens (e.g., fibril-forming collagens 
and non-fibril forming collagens), glycoproteins (e.g., fibronectins, elastin, laminins, 
vitronectin, etc), proteoglycans, extracellular proteases, and ECM receptors (5, 33, 47). 
ECM in the heart is linked to cellular cytoskeleton by transmembrane molecules, mainly 
integrins, which provides a physical connection between cytoskeleton and ECM proteins 
(5, 33, 107). The interactions among ECM, cytoskeleton, and cell through integrins 
might be very important during cardiac remodeling (47, 56, 102).  Although 
glycoproteins and proteoglycans are essential in proper cardiac geometry and various 
functions of the ECM, including signaling and turnover of the ECM (8), the most 
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abundant structural components of the ECM are collagens (5), which are produced 
primarily by fibroblasts either on the membrane-bound ribosomes of the rough 
endoplasmic reticulum (ER) or placed within the ECM, respectively (64).  
Cardiac fibroblasts are the principal cell type, which are approximately two 
thirds of myocardial cells (23, 49). Cardiac fibroblasts play an important role in cardiac 
development, myocardial structure, cell signaling, and electro-mechanical function of 
the myocardium (23). Cardiac fibroblasts grow in a complex myocardial environment, 
contributing to the production and deposition of most ECM proteins such as collagens 
and fibronectin in the cardiac interstitium (4, 79). Cardiac fibroblasts possess a variety of 
receptors for humoral factors and can functionally respond to mechanical stimuli (130). 
Conversely, cardiac fibroblasts can synthesize and release autocrine/paracrine factors 
(e.g., tumor necrosis factor-α, transforming growth factor-β, angiotensin ІІ) and ECM 
proteins, which are thought to play a key role in ECM remodeling (6). 
The ability to synthesize the ECM components depends on cell types in the heart. 
For example, fibroblasts and smooth muscle cells synthesize collagen types І and ІІІ and 
fibronectin, whereas cardiac myocytes and endothelial cells produce collagen type Ⅳ 
(33). In addition, laminin is produced by cardiac myoctyes, smooth muscle cells, and 
endothelial cells (33). Alterations in the profile of ECM proteins can play a profound 
influence on the form and function of heart.    
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Cardiac ECM remodeling and aging 
The aging heart is characterized by decreased myocyte number, increased 
myocyte size, and increased extracellular matrix compared with younger heart (3). Cell 
death by apoptosis or necrosis is very critical determinant of ECM remodeling because it 
induces a loss of contractile tissue, reactive compensatory hypertrophy of remaining 
myocytes, and ECM remodeling including interstitial fibrosis (59, 109). These 
phenotypic changes of the myocardium during aging occur in the mainly left ventricle. 
For example, apoptosis, programmed cell death, is localized into the left ventricle, 
suggesting that it is initiated by mechanical factors (61). 
Overall, myocardial remodeling is determined by the consequence of changes in 
cardiac myocytes and disruption of ECM homeostasis. The ECM remodeling caused by 
aging results in myocardial remodeling, contributing to rearrangement of normally 
existing structures (92, 121). The ECM remodeling also occurs in dilated 
cardiomyopathy (91) and myocardial infarction (77). The ECM is a fibrillar network that 
embeds cardiomyocytes and the whole cardiac structure. The ECM remodeling is a 
critical part of mortality in the elderly. In particular, aging seriously affects the 
myocardial structure and function, as the fundamental biological process of aging is 
intimately associated with an increased arterial hypertension, atherosclerosis, and 
decreased physical activity.              
Fibrosis is a complicated tissue response that causes the excessive deposition of 
ECM, especially collagens (66). Fibrosis, one of the major biological determinants of 
cardiac remodeling, is an increased collagen content and concentration, resulting in 
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increased myocardial stiffness and cardiac dysfunction. Fibrosis is multifactorial, and it 
is resulted from aging, myocardial ischemia, inflammatory processes, hormones, 
vasoactive peptides, or diabetes (121). There are two different types of fibrosis, namely, 
reparative fibrosis and reactive fibrosis (121). Reparative fibrosis occurs as a reaction to 
the loss of cardiac myocytes due to apoptosis or necrosis, located mainly in interstitium. 
In contrast, reactive fibrosis occurs as a reaction to inflammation without the loss of 
cardiac myocytes, observed in primarily perivascular area (115). Reparative and reactive 
fibrosis usually coexists during ECM remodeling. For example, after myocardial 
infarction, reparative fibrosis is organized as a scar and reactive fibrosis and 
compensatory cardiac hypertrophy surround it (131).  
There are converging reports suggesting that myocardial fibrosis occurs in 
senescent hearts both in rats and humans (3, 9, 41, 80, 87). Furthermore, there is 
emerging evidence that indicates that aging is associated with increased cardiac 
fibroblasts (23). The ECM remodeling with aging including modifications of ECM 
protein synthesis and degradation would suggest that the aging heart might be unable to 
adapt to an increased load well (18, 35, 85). 
      
Collagens in the heart 
Collagens are a regulated family of ECM proteins that provide structure and 
optimize function of the heart (8). Presently, more than 20 collagen types have been 
identified in various vertebrate tissues. Collagen is the most abundant protein in ECM 
and forms the essential mechanical building blocks, providing tensile strength and 
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resisting stretch (59). The collagen is composed of three α-chains called triple helix or 
tropocollagen molecule.  The common structure of collagens is repeating amino acid 
sequence (Gly-X-Y) that comprises the collagen chain. Most of collagens are present in 
the forms of polypeptide chains called collagen molecule or α-chain, consisting of 
glycine, proline, and hydroxyproline with hydroxylysine (5, 59).  
In addition, mechanical integrity of the collagen fibers by the formation of 
intramolecular or intermolecular cross-linking plays an important role in overall cardiac 
structure and function (37). Collagen cross-linking is accomplished through lysyl 
oxidase catalyzed deaminate where lysine and hydroxyline moieties form allysine and 
hydroxyallysine covalent bonds (59). These collagen cross-linking causes changes in the 
structure and function of the collagen matrix resulting in cardiac stiffness and 
dysfunction in contractile properties, and is assessed by hydroxylysylpyridinoline (HP). 
(37). The collagens are essential for maintaining alignment of the myofibrils within the 
myocyte through a collagen-integrin-cytoskeleton-myofibril system (101).   
Structurally, the network of collagens exists at three levels named i) endomysium 
surrounding individual muscle fibers, ii) perimysium surrounding groups of myocytes, 
and iii) epimysium surrounding the entire muscle (37). Connective tissue consists mainly 
of collagen, and to a much lesser extent, fibronectin, laminin, and elastic fibers (24, 32). 
For example, collagen and connective tissue occupy over 10% of extramyocyte space, 
and collagen itself occupies 4% of the space in the rabbit heart (44).   
The collagens can be divided into two major classes, the fibrillar-forming and 
non-fibrillar-forming collagens (5, 59). Among collagens, five of collagens (І, ІІ, ІІІ, V, 
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and XІ) form fibrils (59). The fibril-forming collagens provide the structural framework 
of tissues. In particular, collagen types І and ІІІ in myocardial collagens are 
predominantly interstitial collagens in the heart that surround cardiac myocytes and the 
coronary microcirculation, providing structural integrity for the cardiomyocytes (47, 59, 
63, 92). Type I collagen type makes up approximately 85% and type III collagen 11% of 
total collagen in the heart (37, 59).  
Although collagen types І and ІІІ coexist in the extracellular matrix, especially 
both in the perimysium and endomysium (37), there are some differences due to the 
composition of the α-chains that comprise the collagen triple-helix.  Collagen type І is a 
hybrid, consisting of two identical α1 (І) chains and one α2 (І) chain that form the 
superhelix (5). Collagen type І is thick, yellow or red, strong fibers and is thought to play 
an essential role in providing structural stability to tissues (35). This is in part supported 
by the fact that the collagen type І has less distensible properties than collagen type ІІІ 
(35). In contrast, collagen type ІІІ contains three identical α1 (ІІІ) chains (5).  Collagen 
type ІII is thin, greenish fibers, and fine reticular network in most soft connective tissue 
unlike the larger fibers that are derived from collagen type І molecules (35). Collagen 
type І provides high tensile strength and stiffness to tissues, whereas collagen type ІІІ 
provides high compliance to tissues (59, 83). So, the ratio of collagen type ІІІ to І has 
been implicated in functional properties of the heart, with a higher ratio of collagen type 
ІІІ to І indicating more compliant tissue and a lower ratio of collagen type ІІІ to І 
indicating a stiffer, less compliant tissue (59, 83).      
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Aging and cardiac collagens 
Myocardial remodeling during aging is related with changes in the amount and 
organization of ECM components (121). In particular, myocardial collagens in ECM 
undergo remodeling with aging. A healthy arrangement of collagens provides a 
framework for myocyte sheath sliding, transmittance of force from myocyte to the 
ventricular chamber, prevents excessive stretch and damage, and preserves heart 
function (37). However, excessive accumulation of collagen matrix is upregulated in a 
number of cardiovascular diseases (26, 132). Moreover, aging also increases the rate of 
ventricular collagen turnover and deposition by fibroblasts called fibrosis (8, 124, 125).  
Fibrosis with aging is characterized by increased collagen content (35, 54), 
decreased collagen solubility, and increased collagen cross-linking (124, 125). This 
increase in collagen deposition during aging may be thought to result from a 
combination of cellular events including increased collagen synthesis and decreased 
degradation. The collagen might become more resistant to collagenase degradation with 
aging (59). Excessive accumulation of collagen in the heart could lead to tissue stiffness, 
increase the incidence of arrhythmias, disrupt electronic communication between 
myocytes, and result in diastolic and systolic dysfunction and heart failure (8, 30).   
Previous studies have demonstrated age-related changes in cardiac collagen 
concentration (19, 35, 54, 76, 85, 124, 125, 135). Debessa et al. (35) indicated that the 
number and thickness of Type I collagen increased from adulthood to old age in human 
heart. Studies in animal hearts also provided consistent evidence of an increase in 
myocardial collagen concentration with aging (18, 85, 89, 124, 125, 135). For example, 
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in the left ventricle of rat, the collagen concentration (hydroxyproline) has been shown 
to increase almost double from 5 to 26 months of age (125). These findings were 
confirmed by Nguyen et al. (85), who examined the collagen concentration in the left 
ventricles of Fischer 344 rats at 6, 18, and 24 months of age. Their results revealed that 
the collagen concentration, as determined by hydroxyproline assay, progressively 
increased during aging with greatest increments from 6 to 18 months, then leveling off at 
24 months. Similar findings were previously described by Mays et al. (83), who found a 
gradual increase in collagen concentration, based on hydroxyproline levels between 2 
weeks and 24 months of age. In addition, Lindsey et al. (76) recently reported that total 
collagen levels increased with advancing age. Taken together, the increased collagen 
content/concentration might be an integral part of ECM remodeling that takes place in 
the left ventricle consequent to the natural aging process leading to an increase in 
myocardial passive stiffness and impaired contractile function.          
  A few studies also have showed age-related increases in collagen cross-linking 
in cardiac muscle (124, 125). Increased collagen cross-linking could be implicated as a 
potential mechanism for an impaired extensibility and increased stiffness in aged heart. 
For example, Thomas et al. (124, 125) reported that there were significant overall aging–
related increases in collagen cross-linking in the both left ventricle and septum. In 
addition to the heart, skeletal muscle also showed the same phenomena that collagen 
content (48, 65, 84) and collagen cross-linking (48, 90, 97) significantly increased from 
young to senescence in skeletal muscle.  
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Exercise and cardiac collagens 
Alterations in collagen profile have been shown to occur following exercise 
training in heart (124, 125) and skeletal muscle (48, 65, 138). For example, Thomas et 
al., (124) observed that ten weeks of treadmill exercise training reduced age-induced 
upregulation of collagen concentration (percent collagen) in the left ventricle septum of 
rats. The collagen cross-linking (HP) of left ventricle free wall was significantly lower in 
old trained rats, compared with their sedentary counterparts (124, 125). 
Conflicting results were also reported by others. Burgess et al. (17) suggested 
that total collagen concentration (hydroxylproline) of rat left ventricle did not change by 
10 weeks of treadmill exercise training. In addition, collagen type ІІІ -to-І ratio was not 
altered by exercise training in the rat heart (17).  Woodiwiss et al. (134) found that 
demonstrated that 16 weeks of habitual voluntary wheel running had no effects on 
myocardial collagen concentration and cross-linking in the rat left ventricle, although 
cardiac stiffness was reduced. Similarly, Jin et al. (57) showed that mRNA levels of 
collagen types І and ІІІ did not change with 13 week treadmill exercise training in the rat 
heart. So, based on previous findings, the role of exercise training on collagen 
concentration and cross-linking in the heart remains to be clarified. 
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Fig. 1. Collagen ECM turnover signaling in the heart. Altered mechanical stress and 
oxidative stress may stimulate TNF-α, TGF-β, and MMP. TNF- α may stimulate MMP 
and inhibit TIMP. However, TGF-β may inhibit MMP and stimulate TIMP and 
myofibroblast. Finally, MMP degrades collagens, but TIMP and myofibroblast inhibit 
collagen degradation and promote collagen synthesis, which determine collagen ECM 
remodeling.     
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Regulation of cardiac collagen ECM 
Collagen ECM plays an important role in cardiovascular function, and 
remodeling in the ECM contributes to myocardial dysfunction (47, 59). Myocardial 
failure and remodeling are usually characterized by collagen accumulation, collagen 
fibril disruption, myocyte loss via apoptosis or necrosis, and impaired rearrangement of 
structure (121). In particular, accumulation of collagen ECM with aging in the heart 
could create a mechanical environment and stress distribution that contributes 
diminished systolic performance, decreased compliance, and diastolic dysfunction (37).  
Therefore, the balance of ECM remodeling via collagen ECM synthesis and 
degradation is essential for normal cardiac structure and function (59). Collagen ECM 
remodeling is modulated by regulatory proteins, hormonal factors, cytokines, and growth 
factors (8, 23). Thus an understanding of upstream ECM regulatory factors including 
matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), 
tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β), and 
myofibroblasts is necessary for gaining new insights into managing cardiac remodeling 
and dysfunction with aging (Fig. 1). 
 
Cardiac MMPs and TIMPs 
This extracellular collagen matrix depends on a balance between matrix 
metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), which 
determines cardiac remodeling (1, 59). MMPs are an endogenous family of enzymes that 
degrade ECM proteins, which are responsible for ECM remodeling in a number of 
 14
physiological and pathological process (1, 127). To date, the MMP family consists of 
more than 20 unique proteins in vertebrates (60). Most of MMPs are inactive enzymes 
that are activated in the extracellular matrix. It has been shown that important MMPs 
highly related with myocardial remodeling are collagenases (e.g., MMP-1 and MMP-
13), gelatinases (e.g., MMP-2 and MMP-9), stromelysin (e.g., MMP-3), and the 
membrane-type MMP (e.g., MMP-14) (63). These kinds of MMPs degrade 
predominantly collagen types І and ІІІ in the ECM of the heart (60, 63, 111).  
MMPs are Ca2+-and Zn2+-dependent proteases that are usually synthesized as an 
inactive form or pro-MMP, which will be activated by the cleavage of an amino-terminal 
propeptide domain either by autoproteolysis, another MMP, or serine protease (59). For 
example, MMP-14 activates MMP-2, which requires TIMP-2 binding to its active place 
(69). MMPs in the heart are expressed primarily by fibroblasts (27) and cardiomyocytes 
(31). Most pro-MMPs are stored extracellular bound to different ECM components (59).  
Upon stimulation, activated MMPs degrade the ECM proteins including collagens, 
fibronectin, laminin, gelatin, and proteoglycan. Therefore, MMPs are significant 
regulators of ECM turnover in the heart, thus contributing to physiological function as 
well as pathology.  
In contrast, activity of MMPs is in part regulated by endogenous inhibitors (59). 
TIMPs are specific MMP inhibitors in the ECM (78). The role of TIMPs is to prevent 
excessive ECM degradation by MMPs. There are 4 TIMPs identified in vertebrates, 
TIMP-1, -2, -3, and -4, acting as the natural inhibitors of active forms of all MMPs 
through binding to MMPs in a 1:1 ratio (30). Among them, TIMP-1, -2, and -4 are 
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soluble forms, whereas TIMP-3 binds to the ECM via heparan sulfate proteoglycans 
within the ECM (70, 136).  
The balance between MMPs and TIMPs plays a critical role in the process of 
cardiac ECM remodeling which contributes to cardiac function (110). Based on previous 
findings, it appears that cardiac ECM remodeling is generally associated with enhanced 
MMP and reduced TIMP activities (59). However, there are differences in the studies. 
For example, the levels of TIMP-1 were either repressed (128) or increased (123) in 
dilated cardiomyopathy patients.  
It has been shown that inhibition of MMP activity is beneficial during cardiac 
remodeling and wall stress following injury due to myocardial infarction (93, 119). For 
example, Rohde et al. (99) indicated that a broad range MMP inhibitor attenuated left 
ventricular dilatation 4 days after infarction in a mouse myocardial infarction. In 
addition, inhibition of MMP-9 activity attenuated left ventricular enlargement and 
collagen content after myocardial infarction (39). In addition, heart failure is associated 
with alterations in MMPs including increased MMP-3 and MMP-9, and decreased 
MMP-1, while MMP-2 was unchanged (123). Therefore, MMP inhibition might be a 
new therapeutic treatment to control cardiac dysfunction and failure (93).      
Studies investigating age-related alterations of MMP and TIMP expression in the 
heart remain limited. A few publications indicated that MMP levels increased, and TIMP 
levels decreased in the rat heart with advancing age (76, 82). For example, Lindsey et al. 
(76) found that the levels of MMP-3, MMP-8, MMP-9, MMP-12, and MMP-14 
increased, and the levels of TIMP-3 and TIMP-4 decreased in the insoluble fraction of 
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old mice, compared with young adult mice, suggesting that aging is associated with 
increased ECM degradative capacity. However, much different findings were reported 
by Robert et al (98). Their results indicated a 40-45% decrease in both MMP-2 and pro-
MMP-1 activity and mRNA in 24-month-old rat heart, suggesting that the reduction of 
ECM degradation pathway by MMP allows accumulation of collagen and promotion of 
age-associated fibrosis. Thus, the current literature is unclear about MMP or TIMP 
expression with aging in the heart as both decreased (98) and increased (76) levels have 
been reported. In addition, most of findings did not measure MMPs or TIMPs in the 
insoluble fraction, associated with structural ECM proteins such as collagen (82, 98). 
Moreover, it is unknown if exercise training modulated age-associated effects on MMP 
and TIMP levels in the heart.  
 
Cardiac TNF-α 
Upstream regulators of MMPs and TIMPs include inflammatory cytokines in the 
heart (118, 127). It seems likely that the cytokines may lead to an imbalance in 
myocardial MMP/TIMP ratio resulting in altered myocardial ECM architecture and 
development of left ventricle remodeling and dysfunction (59, 118). Among cytokines, 
tumor necrosis factor-α (TNF-α), a pro-inflammatory cytokine, can increase the matrix 
collagen degradation by upregulating MMP activity and downregulating TIMPs (59, 
118).  TNF-α has a variety of different biological capacities in response to one or more 
different forms of environmental stress in heart failure, including LV dysfunction, 
cardiomyopathy, LV remodeling, abnormalities of mitochondrial energetics, increased 
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production of reactive oxygen, and cardiac myocyte apoptosis (81). In particular, LV 
remodeling by TNF-α is involved in alterations in the biology of the cardiac myocyte, 
progressive myocyte loss, and alterations in the extracellular matrix including synthesis 
and degradation of collagen matrix (81).      
Significantly increased levels of TNF-α have been demonstrated in patients with 
dilated or ischemic cardiomyopathy, (88, 108) and in animal models of myocardial 
infarction (55). Furthermore, Li et al. (74) suggested that cardiac overexpression of 
TNF-α in transgenic mice caused increases in MMP-2 and MMP-9 activity as well as 
marked diastolic dysfunction. In isolated cardiac fibroblasts, TNF-α decreases collagen 
synthesis, increases MMP expression, and decreases TIMP expression (75, 117). In 
contrast, Sivasubramanian et al. (116) reported that there were significant decreases in 
total MMP activity and elevated TIMP-1 levels in the cardiac overexpression of TNF-α 
in transgenic mice, suggesting a possible mechanism for the increase in myocardial 
fibrosis. Mann (81) also showed that TNF-α promoted cardiac fibroblast proliferation 
and fibrosis. Although the mechanisms by which TNF-α affect MMP and TIMP may 
depend on in vitro and in vivo models, TNF-α may indeed induce an imbalance in 
MMP/TIMP ratio, remodeling and fibrosis in the heart.  
There are controversial evidences regarding the effects of aging on TNF-α in the 
heart. Some findings suggest that there is no change of TNF-α with advancing age in the 
heart (105) and serum (103). In contrast, others indicate that TNF-α increases with aging 
in the vessels (34) and serum (104). So, the role of TNF-α in aging heart remains 
unclear.    
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However, there is emerging evidence in support of exercise training-induced 
suppression of TNF-α (7, 10, 71, 72). For example, after 12 weeks of exercise, there was 
a significant decrease in plasma TNF-α levels in patients with heart failure (71). These 
findings were confirmed by LeMaitre et al. (73), who showed that 6 weeks of bicycle 
exercise training in chronic stable heart failure patients attenuated the circulating levels 
of TNF-α and TNF-α receptor 2.        
 
Cardiac TGF-β  
Transforming growth factor-β (TGF-β) is a multifunctional cytokine that plays an 
important role in cell migration, proliferation, differentiation, apoptosis, and ECM 
protein production (2, 8, 106, 114). TGF-β, an anti-inflammatory cytokine, is a potent 
stimulator of collagen synthesis (112, 118).  It consists of three isoforms, TGF-β1, TGF-
β2, and TGF-β3 that are structurally and functionally closely related to one another (2). 
The TGF-β released from platelets and leukocytes stimulates the synthesis of ECM 
components including collagens, fibronectin, proteoglycans, and integrins in tissue 
repair after injury (13). It mediates collagen synthesis through increasing transcription 
and decreasing collagen degradation via reduced MMPs or enhanced TIMPs, thus 
favoring an accumulation of ECM and especially of collagen (12, 40, 118). For example, 
Seeland et al. (112) suggested that the overexpression of TGF-β1 in transgenic mice 
resulted in increased protein expression of collagen types І and ІІІ, reduced interstitial 
collagenase protein activity and mRNA expression, and increased TIMP-1, -2, and -4 
protein levels in the heart. Additionally, in cardiac fibroblasts, procollagen formation 
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was stimulated by mechanical loading and TGF-β (20). Moreover, there is an interesting 
evidence that indicates that the addition of TGF-β1 to cultured cardiac fibroblasts 
increases ECM mRNAs (42).  
Acute exercise or mechanical loading may stimulate TGF-β synthesis in the heart 
(22), smooth muscle (50), skeletal muscle (14, 46), and circulating blood (52, 53) as a 
physiological response. For example, Calderone et al. (22) reported that TGF-β1 mRNA 
increased in the left ventricle of a voluntary exercise rat model of physiological cardiac 
hypertrophy. However, excessive and chronic expression of TGF-β is associated with 
many fibrotic diseases including cardiac fibrosis after infarction, lung fibrosis, and 
scarring (2, 13). TGF-β may play a role in stimulating abnormal accumulation signaling 
of ECM proteins in the cardiovascular diseases (58). Rosenkranz et al. (100) showed that 
TGF-β overexpression in the transgenic mice heart resulted in cardiac hypertrophy and 
fibrosis. Similarly, Brooks & Conrad (15) found that TGF-β1 deficient old mice heart 
exhibited a decrease in myocardial fibrosis and reduced myocardial stiffness, indicating 
the role of TGF-β to contribute to ECM component synthesis in the heart.   
Although several findings suggested that pro-inflammatory cytokine, TNF-α can 
increase the collagen matrix degradation by upregulating MMP activity and 
downregulating TIMPs (59, 75, 88, 108, 117, 118), which is antagonistic to the role of  
TGF-β,  Sivasubramanian et al. (116) interestingly demonstrated that TGF-β1 and TGF-
β2 protein levels were significantly increased in the cardiac overexpression of TNF-α 
transgenic mice, providing one potential explanation for the increase in myocardial 
fibrosis. 
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Cardiac myofibroblasts 
Myofibroblast is a differentiated cell type from fibroblast characterized by 
increased ECM protein synthesis called fibrosis formation, providing an essential role 
for ECM remodeling during normal and pathological wound healing (30, 96, 126, 129). 
Myofibroblasts as a smooth-muscle like fibroblasts might be produced from progenitor 
stem cells in the heart or from the circulation, and secret cytokines (e.g., TNF-α), growth 
factors (e.g., TGF-β), chemokines, and inflammatory mediators (96). In addition, 
differentiation to the myofibroblast may be induced by transforming growth factor-β1 
(TGF-β1) (45, 126).  
 Myofibroblast expression may be not detectable in the normal healthy adult 
hearts, while myofibroblasts are often associated with injured heart such as myocardial 
infarction for wound healing (8, 94, 133). In particular, Poobalarahi et al.(94) reported 
that increased type I collagen synthesis by myofibroblasts was accompanied by a 
significant increase in collagen deposition into insoluble ECM in the heart. Accordingly, 
myofibroblasts appear to play a critical role in production of cardiac ECM in response to 
injury. In addition, differentiated myofibroblasts are unique in that they express α-
smooth muscle actin (α-SMA) unlike adult fibroblasts (28, 96, 113). 
Expression of α-SMA positive myofibroblasts appears to be regulated by 
transforming growth factor-β1 (TGF-β1) (28, 36). A similar finding was also reported 
that TGF-β1 promoted the conversion of myofibroblasts in vitro (45). Additionally, 
Kuwahara et al. (67) found that TGF-β1 function-blocking antibodies administered to 
pressure-overload rats prevented the myofibroblasts conversion in cardiac interstitium 
 21
and subsequent increases in mRNA of type I collagen as well as diastolic heart failure. 
Interestingly, Porter et al. (95) showed that tumor necrosis factor-α (TNF-α) via a TNF-
R1 receptor also increased myofibroblast proliferation in human heart.            
Although increased gene expression of ECM proteins by myofibroblasts is well 
documented, much less is known regarding effects of aging and exercise training on 
myofibroblasts in the heart. Only one result has been published regarding the effect of 
exercise training on α-smooth muscle actin in the normal heart (57). That result indicated 
that there was no change of mRNA levels of α-smooth muscle actin in the young (6-8 
wk) rat heart after 13 week treadmill exercise training. 
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CHAPTER II 
METHODS 
 
Animals 
Young (3 months) and old (31 months) male Fischer 344 × Brown Norway F1 
hybrid (F344BNF1) rats were used at the beginning of the study. F344BNF1 rats are a 
preferred NIH aging model with greater longevity (33 mo) than F344 rats (24 mo), as 
F344BNF1 rats are less susceptible to mortality from pathology including cancer than 
F344 rats (86). Rats were purchased from the NIA colony and cared for at the 
Comparative Biology Laboratory facility at Texas A&M University in accordance with 
NIH and University Laboratory Animal Care Committee standards. Rats were housed in 
a temperature-controlled (23 ± 2°C) room with a 12:12-h light-dark cycle, and water and 
rat chow provided ad libitum.   
 
Exercise training protocol 
To test the exercise training regulation of ECM remodeling in the aging heart, 
rats in the exercise groups trained at a relative intensity of approximately 70% of 
maximal aerobic capacity based on previous work (29, 68). Rats walked briskly on a 
motor-driven treadmill for 45 min/day at 12° incline, 5 d/wk for 12 wk. Running speeds 
were 20 m/min (young) or 10 m/min (old) to reach the desired intensity. The first 5 days 
were an acclimation period for the rats to adapt to the treadmill exercise at 10 m/min for 
10 min without incline. Rats were gradually conditioned to perform treadmill exercise 
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for 45 min/day over the first 4 wk of the 12 wk training program. Heart-to-body weight 
ratio and skeletal muscle citrate synthase activity were assessed as an indicator of the 
efficacy of the exercise training regimen. This exercise regimen has previously been 
shown to elevate citrate synthase activity as a marker of oxidative mitochondrial 
capacity in skeletal muscle (29, 68). 
 
Experimental design 
To determine whether exercise training attenuates age-induced changes in ECM 
remodeling and signaling in the heart, the rats were randomly assigned to one of the 
following experimental groups (n=10/group): 1) young sedentary controls (YS), 2) 
young exercise trained (YE), 3) old sedentary controls (OS), and 4) old exercise trained 
(OE). Rats in the exercise training groups were anesthetized with sodium pentobarbital 
(50 mg/kg) 48 h after the last bout of exercise training to avoid influence of the last acute 
exercise bout. The left ventricle was then quickly extracted, weighed, and placed in ice-
cold phosphate-buffered saline (PBS) (pH=7.4).  The samples were frozen in liquid 
nitrogen and stored at –80°C until analyses. 
 
Homogenization procedure 
Left ventricle samples were minced into fine pieces and homogenized (26:1 v/w) 
in ice-cold (4°C) lysis buffer solution (pH=7.40) containing the following: 20 mM 
HEPES, 350 mM NaCl, 20% glycerol, 1% Igepal-CA630, 1 mM MgCl2, 0.1 mM DTT, 
0.5 mM EDTA, 0.1 mM EGTA, and protease inhibitor cocktail (Roche Applied 
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Science). Minced muscle samples were homogenized using a ground glass on ground 
glass homogenizer (Bellco Biotechnology) at 4°C, and then isolated for soluble fraction, 
nucleosome fraction, and insoluble fraction as the following. The tissue homogenates 
were first centrifuged for 10 min at 3000 g at 4°C, and supernatant was withdrawn from 
the first centrifugation. The supernatant was used as the soluble fraction after second 
centrifugation at 10,000 g for 10 min at 4°C. The resuspended pellet from first 
centrifugation in complete lysis buffer was centrifuged again at 12,000 g for 30 min at 
4°C. This supernatant was used as the nucleosome fraction.  
For insoluble fraction, the second pellet was resuspended by boiling in SDS-
PAGE sample buffer including 50 mM Tris (pH 6.8), 0.1 mM DTT, 2% SDS, 1 mM 
glycerol, and 1.67 mM EDTA. Total protein concentration of each fraction was 
measured using BCA protein assay reagent kit (Pierce) at 562 nm absorbance using 
spectrophotometry. 
 
Measurement of citrate synthase activity 
Citrate synthase activity with gastrocnemius and soleus skeletal muscles was 
measured as described previously (72). It was used as a marker of oxidative capacity in 
skeletal muscle and is indicative of mitochondrial density and function. In brief, reaction 
cocktail (1.0 ml; 0.1mM DTNB, 0.07% Triton X-100, 0.1 mM acetyl CoA in 100 mM 
potassium phosphate buffer with 10 mM EDTA, pH 7.40) was combined with 10 μl 
samples of 1:50 homogenates in a cuvette and incubated for 5 min. The substrate 
oxaloacetate (50 μl: 0.1 mM in buffer) was added and then the reaction was commenced. 
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After vortexing the final mixture, the absorbance was measured from 1 to 4 min at 412 
nm using spectrophotometry. Enzyme activity was expressed as Units per g wet weight 
of muscle.    
 
Measurement of TNF-α 
TNF-α activity levels in left ventricle muscle tissue homogenates were quantified 
using an ELISA kit designed specifically for rat use (Pierce Biotechnology). In brief, 
following adding 50 µl of pre-treatment buffer, 50 µl of samples or standards were 
transferred into each well of microplate and incubated at room temperature (RT) for an 
hour. After three times washing, 50 µl of biotinylated antibody reagent were added to 
each well and incubated for an hour at RT. After three times washing, 100 µl of 
streptavidin-HRP reagent were added to each well. After covering the microplate, it was 
incubated for 30 min at RT. After washing three times, 100 µl of TMB substrate solution 
were added to each well, and developed at RT for 10 min. After that, the reaction was 
stopped by adding 100 µl of stop solution. Finally, the absorbance on a plate reader at 
450 nm minus 550 nm was measured. 
 
Western immunoblot analysis 
Protein levels were determined via Western immunoblot analysis.  Separating gel 
(375 mM Tris-HCl; pH=8.8; 0.4% SDS; 10% acrylamide) and stacking gel (125 mM 
Tris-HCl; pH=6.8; 0.4% SDS; 10% acrylamide) solutions were made, and 
polymerization then initiated by TEMED and ammonium persulfate.  Separating and 
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stacking gels were then quickly poured into a Bio-Rad Protein III gel-box (Bio-Rad).  
Thirty µg of protein from soluble fraction and insoluble fraction of left ventricle in 
sample buffer (125 mM Tris-HCl; pH=6.8 with 2% SDS, 30 mM DTT, 25% glycerol) 
were loaded into the wells of the 10% polyacrylamide gels, and electrophoresed at 150V. 
The gels were transferred at 30V overnight onto a nitrocellulose membrane (Bio-Rad). 
Equal loading and transferring of proteins to the membrane in each lane were confirmed 
through Ponceau-S staining. Membranes were blocked in 5% nonfat milk in PBS with 
0.1% Tween-20 for 6 hours. After blocking, membranes were incubated at room 
temperature in PBS for 12 hours with the appropriate primary antibodies including 
collagen type Ι (1:200, Santa Cruz),  collagen type ΙΙΙ (1:1000, Santa Cruz), MMP-1 
(1:1000, Calbiochem), MMP-2 (1:2000, Santa Cruz), MMP-3 (1:5000, Chemicon), 
MMP-9 (1:8000, Chemicon), MMP-14 (1:5000, Chemicon), TIMP-1 (1:1000, 
Chemicon), TIMP-2 (1:2000, Calbiochem), TIMP-3 (1:2000, Cedarlane), TIMP-4 
(1:1000, Chemicon), TGF-β1 (1:250, R & D), and α-SMA (1:1000, Sigma). Following 
three washings in PBS with 0.4% Tween-20, horseradish peroxidase (HRP)–conjugated 
secondary antibodies, an enhanced chemiluminescence (ECL) detection system 
(Amersham) and Kodak film were used for visualization. The membranes were stripped 
and re-probed with GAPDH (1:4000, Advanced Immunochemical), β-actin (1:800, Cell 
Signaling), and α-tubulin (1:200, Santa Cruz) antibodies to verify equal loading among 
lanes. Densitometry (as area × grayscale relative to lane background) was performed 
using a scanner interfaced with a microcomputer and the NIH Image J software program. 
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Morphological analysis 
Morphological analysis and tissue sectioning were conducted as described 
previously (68).  Briefly, cross-sections of left ventricle were cut (8 µm thick) in a 
cryostat (Shandon) pre-cooled to -20°C at halfway between the apex and atria, placed on 
slides and air-dried for 30 min. For assessment of fiber cross-sectional area, fiber 
number, and extramyocyte space, cross-sections were rinsed three times in PBS and 
stained with two drops of hematoxylin, incubated for 1 min at room temperature. 
Hematoxylin was chosen for visualization of morphology, identification of nuclei 
number, location, and extramyocyte area. Stained sections were then rinsed with PBS 
and air dried before mounting in Vectamount medium (Vector Laboratories). Mounted 
muscle cross-sections were then dried overnight prior to analyses.  Finally, left ventricle 
cross-sectional images were visualized and captured using a microscope (Axiophot2, 
Carl Zeiss) at a magnitude of 200X.   
 
Masson’s trichrome staining 
Extramyocyte connective tissue was estimated via collagen staining using an 
adaptation of the Masson’s trichrome technique. Briefly, 8 µm frozen left ventricle 
cross-sections were cut at -16°C and placed on a slide. After a 20 min drying period, 
slides were placed in a Columbia jar and fixed overnight at room temperature in Bouin’s 
solution. Slides were then rinsed in distilled water for 3 min, the running tap water for 5 
min. Cross sections were then stained in Weigert’s hematoxylin for 15 min, and washed 
in distilled water, then running tap water for 5 min. Muscle fibers were then stained with 
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Biebrich scarlet-acid fuschin for 15 min, then washed in dH2O for 5 min. After 
differentiation in phosphomolybdic-phosphotungstic acid solution for 15 min, sections 
were transferred directly into aniline blue solution for 12 min.  The sections were 
differentiated in 1% acetic acid solution for 3 min, dehydrated in 95% and 100% 
ethanol, then cleared in xylene. In this techniques left ventricle muscle fibers were 
stained bright red and collagen fibers bold blue. Images were captured on a Zeiss Axio-
Vision-series microscope and software, and quantified using the NIH Image J program. 
 
Statistical analysis 
 Data were analyzed with two-way ANOVAs (aging × exercise training) to 
determine the existence of mean differences for age and exercise effects. When 
appropriate, a Fisher’s LSD was performed for post hoc comparisons. All values were 
presented as mean ± SEM. Statistical significance was established at P < 0.05. 
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CHAPTER III 
RESULTS 
 
Body weight, heart weight, heart-to-body weight ratio, and citrate synthase activity 
 For body weight (BW), after 12 weeks of treadmill exercise training, both aging 
and training effects were observed, with old animals being significantly heavier than 
their younger cohorts, and exercise rats being significantly lighter than sedentary 
counterparts in both young and old groups (Table 1). In particular, although BW of old 
sedentary rats increased (+19.2 g) after 12 weeks of exercise training periods as they 
grew, BW of exercise groups was markedly reduced (-67.2g) after exercise training.    
 Heart weights (HW) from the old groups (OS, OE) were also significantly 
heavier than those of younger animals (YS, YE) (Table 1). For example, the HW of old 
sedentary group was 61.8% higher than younger sedentary group. But there was no 
absolute hypertrophy of the heart in either exercise trained groups compared with age-
matched controls.   
 12 weeks of endurance exercise training significantly increased Heart-to-body 
weight ratio (HW/BW ratio) in the young groups (Table 1). Although no change was 
seen between young controls and old controls, the HW/BW ratio in young exercise-
trained rats was 11.7% higher when compared with young sedentary controls. Even if 
the body weight of old exercise group significantly decreased after exercise training, 
there was no change in HW/BW ratio in old exercise-trained rats due to slightly reduced 
heart weight compared with old controls. 
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We found that citrate synthase activity of soleus muscle (type I muscle) in old 
sedentary controls was significantly lower (-23.03%) compared to the young sedentary 
controls (Table 1). Exercise training resulted in a significant increase (+32.45%) in 
citrate synthase activity of soleus muscle in the young trained group compared to young 
sedentary controls. However, there was no significant difference in citrate synthase 
activity of soleus muscle between old sedentary and old exercise groups.  
 
Extramyocyte space, connective tissue, and morphology 
Left ventricle cross sections were stained with hematoxylin for visualization of 
morphology and extramyocyte space. We focused on the left ventricle as age-related cell 
loss and apoptosis are more prevalent in left ventricle than other parts of the heart (61). 
We observed dramatic remodeling of the left ventricles (Fig. 2) from the old sedentary 
groups when compared with left ventricle sections from the young sedentary animals. 
Remarkably, left ventricle cross sections from the old exercise trained group exhibited 
less age-related remodeling than sedentary rats of matched age (Fig. 2). 
Aging increased the amount of connective tissue and fat in the left ventricles as 
quantified by extramyocyte space. The percentage of extramyocyte space was 
dramatically higher in the old sedentary rats (37.3±2.9%) compared with left ventricles 
in young sedentary animals (9.6±1.0%) (Fig. 3).  In addition, not only was the amount of 
apparent fibrosis higher in old sedentary hearts, but also the geometry of connective 
tissue area in the aging sedentary heart was more weblike (Fig. 2).  
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Exercise training did not alter extramyocyte space in left ventricles from young 
rats (8.2±0.4% vs. 9.6±1.0%). However, exercise training did retard age-induced 
elevation of extramyocyte space in the left ventricle, with 22.4±4% of left ventricle area 
comprising connective tissue, down from 37.3±2.9% in old sedentary groups (Fig. 3). In 
addition, the geometric pattern of extramyocyte area was more linear and regular in the 
old exercise group than the old sedentary heart (Fig. 2). In other words, exercise training 
resulted in a pattern in the old exercise groups that was more similar to young sedentary 
hearts than hearts from old sedentary animals.  
Masson’s trichrome staining revealed greater accumulation of collagen in the OS 
group than YS, as seen from the blue staining (Fig. 4). There was also significant 
remodeling and altered geometry to a more “web-like” appearance. This occurred in the 
myocardium primarily in the 60% of the area towards the endocardial surface. Left 
ventricular samples from old rats that had exercised for 12 weeks exhibited less 
connective tissue and altered geometry (Fig. 4).    
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Table 1. Body weight, heart weight, HW-to-BW ratio, and citrate synthase activity in the 
soleus of young sedentary, young exercised, old sedentary, and old exercised rats. 
BW (g) 
Groups 
before after 
HW  
(g) 
HW/BW  
(mg/g) 
CS  
(μmol/g/min)
YS 311 ± 9 380 ± 11 0.92 ± 0.05 2.40 ± 0.06 32.17 ± 0.75 
YE 310 ± 7 336 ± 6 (*) 0.90 ± 0.02 2.68 ± 0.07 (*) 42.61 ± 0.96 (*)
OS 597 ± 38 (a) 616 ± 20 (a) 1.48 ± 0.04 (a) 2.41 ± 0.09 24.76 ± 0.91 (a)
OE 616 ± 20 (a) 549 ± 18 (a) (*) 1.37 ± 0.04 (a) 2.50 ± 0.08 23.60 ± 0.87 (a)
 
Data are expressed as mean ± SEM. BW, body weight; HW, heart weight; CS, citrate 
synthase activity; YS, young sedentary group; YE, young exercise group; OS, old 
sedentary group; OE, old exercise group. aStatistically significant change relative to 
young sedentary group (P<0.05); *Significant change relative to age-matched group 
(P<0.05). 
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Fig. 2. Hematoxylin-stained cross sections of left ventricles with aging and exercise 
training. The left ventricle cross sections (×200 resolution with 100-μm calibration bar) 
were stained with hematoxylin from the following groups: young (6 months) sedentary 
controls (YS), young exercise-trained (YE), old (34 months) sedentary controls (OS), 
and old exercise-trained (OE). 
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Fig. 3. Effect of aging and exercise training on percent (%) of extramyocyte space. 
Values are mean ± SEM. *Significantly different from control within same age group (P 
< 0.05). aIndicates old sedentary control (OS) is significantly different from young 
sedentary control (YS) (P < 0.05). 
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Fig. 4. Masson’s trichrome-stained cross sections of left ventricles with aging and 
exercise training. The left ventricle cross sections (×160 resolution with 100-μm 
calibration bar) were stained with Masson’s trichrome from the following groups: young 
(6 months) sedentary controls (YS), young exercise-trained (YE), old (34 months) 
sedentary controls (OS), and old exercise-trained (OE). 
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Pro-MMP-1 protein levels 
 There were no aging and exercise training effects on pro-matrix 
metalloproteinase-1 (pro-MMP-1) protein levels in the soluble fraction of left ventricle 
tissues (Fig. 5). Consistently, aging did not affect the protein levels of pro-MMP-1 in the 
insoluble fraction of left ventricle.  But, there was an increased trend (p=0.063) in old 
trained group compared to old controls (Fig. 6) 
 
Active MMP-1 protein levels 
 There were also no aging and exercise training effects on active MMP-1 protein 
levels in the soluble fraction of left ventricle tissues (Fig. 7). However, the protein levels 
of active MMP-1 in the insoluble fraction of old controls were significantly lower (-
12.0%) compared to the young controls (Fig. 8). In contrast, exercise training resulted in 
a significant increase (+12.4%) of active MMP-1 protein levels in the old trained group 
compared to old controls (Fig. 8). However, there was no significant difference in active 
MMP-1 insoluble protein levels between young sedentary controls and young trained 
rats (Fig. 8).    
 
Pro-MMP-2 protein levels 
 The protein levels of pro-MMP-2 in the soluble fraction of left ventricle of old 
controls were significantly lower (-8.9%) than young controls (Fig. 9). However, 
exercise training significantly decreased pro-MMP-2 soluble protein levels by 7.6% in 
the young trained group compared to young sedentary controls (Fig. 9).  
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Fig. 5. Effect of aging and exercise training on pro-MMP-1 protein levels in the soluble 
fraction. Values are mean ± SEM.  
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Fig. 6. Effect of aging and exercise training on pro-MMP-1 protein levels in the 
insoluble fraction. Values are mean ± SEM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
0
50
100
150
200
250
YS YE OS OE
pr
oM
M
P
-1
 in
so
lu
bl
e 
pr
ot
ei
n 
le
ve
ls
(%
 o
f c
on
tro
l)
P = 0.063 
           YS                   YE         OS                   OE 
52 kDa ProMMP-1 
 39
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Effect of aging and exercise training on active MMP-1 protein levels in the 
soluble fraction. Values are mean ± SEM.  
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Fig. 8. Effect of aging and exercise training on active MMP-1 protein levels in the 
insoluble fraction. Values are mean ± SEM. *Significantly different from control within 
same age group (P < 0.05). aIndicates old sedentary control (OS) is significantly 
different from young sedentary control (YS) (P < 0.05). 
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But, there was no significant training effect on pro-MMP-2 soluble protein levels in the 
old group (P=0.116; Fig. 9). In addition, in the insoluble fraction of left ventricle tissues, 
there were no aging and exercise training effects on pro-MMP-2 protein levels (Fig. 10). 
 
Active MMP-2 protein levels 
 The protein levels of active MMP-2 in the soluble fraction in the left ventricle of 
old controls were significantly lower (-36.3%) than young controls (Fig. 11). In contrast, 
we found a significant increase (+24.0 %) in active MMP-2 protein levels with exercise 
training in the soluble fraction of left ventricle from old rats (Fig. 11). But, there was no 
significant training effect on active MMP-2 protein levels in young groups (Fig. 11). The 
active MMP-2 proteins in the insoluble fraction of left ventricle were undetectable in 
both young and old groups.  
 
Pro-MMP-3 protein levels 
 The protein levels of pro-MMP-3 in the soluble fraction in the left ventricle of 
old controls were dramatically higher (+209.6%) than young controls (Fig. 12). 
Although it was not significant, there was an increased trend in pro-MMP-3 soluble 
protein levels with exercise training in old groups (P=0.176; Fig. 12). In addition, we did 
not find training effect on pro-MMP-3 protein levels of the soluble fraction in the young 
groups (Fig. 12).  
In the insoluble fraction of left ventricle tissues, there was no aging effect on pro-
MMP-3 protein levels. Exercise training resulted in a significant increase (+38.3%) of 
pro-MMP-3 protein levels in the old trained group compared to old controls (Fig. 13).       
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Fig. 9. Effect of aging and exercise training on pro-MMP-2 protein levels in the soluble 
fraction. Values are mean ± SEM. *Significantly different from control within same age 
group (P < 0.05). aIndicates old sedentary control (OS) is significantly different from 
young sedentary control (YS) (P < 0.05). 
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Fig. 10. Effect of aging and exercise training on pro-MMP-2 protein levels in the 
insoluble fraction. Values are mean ± SEM.  
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Fig. 11. Effect of aging and exercise training on active MMP-2 protein levels in the 
soluble fraction. Values are mean ± SEM. *Significantly different from control within 
same age group (P < 0.05). aIndicates old sedentary control (OS) is significantly 
different from young sedentary control (YS) (P < 0.05). 
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Fig. 12. Effect of aging and exercise training on pro-MMP-3 protein levels in the soluble 
fraction. Values are mean ± SEM. aIndicates old groups (OS, OE) are significantly 
different from young sedentary control (YS) (P < 0.05). 
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Fig. 13. Effect of aging and exercise training on pro-MMP-3 protein levels in the 
insoluble fraction. Values are mean ± SEM. *Significantly different from control within 
same age group (P < 0.05). 
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However, exercise training had no effect on pro-MMP-3 insoluble protein levels of left 
ventricles in the young age group (Fig. 13).  
 
Active MMP-3 protein levels 
 The proteins of active MMP-3 in both soluble fraction and insoluble fraction of 
left ventricle tissues were not detectable in either young or old groups.  
 
Pro-MMP-9 protein levels 
 There were no aging and exercise training effects on pro-MMP-9 protein levels 
in the soluble fraction of left ventricle tissues (Fig. 14). Consistently, we also did not 
find significant differences in pro-MMP-9 protein levels with aging and exercise training 
in the insoluble fraction of left ventricles (Fig. 15).    
 
Active MMP-9 protein levels 
 The proteins of active MMP-9 in both soluble fraction and insoluble fraction of 
left ventricle tissues were also undetectable in either young or old groups.  
 
Pro-MMP-14 protein levels 
 We found that protein levels of pro-MMP-14 in the soluble fraction of left 
ventricle of old sedentary controls were significantly lower (-23.8%) compared to the 
young sedentary controls (Fig. 16). Exercise training resulted in a significant increase 
(+19.7%) in pro-MMP-14 soluble protein levels in the old trained group compared to old 
sedentary controls (Fig. 16).  
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Fig. 14. Effect of aging and exercise training on pro-MMP-9 protein levels in the soluble 
fraction. Values are mean ± SEM. 
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Fig. 15. Effect of aging and exercise training on pro-MMP-9 protein levels in the 
insoluble fraction. Values are mean ± SEM. 
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Fig. 16. Effect of aging and exercise training on pro-MMP-14 protein levels in the 
soluble fraction. Values are mean ± SEM. *Significantly different from control within 
same age group (P < 0.05). aIndicates old sedentary control (OS) is significantly 
different from young sedentary control (YS) (P < 0.05). 
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Fig. 17. Effect of aging and exercise training on pro-MMP-14 protein levels in the 
insoluble fraction. Values are mean ± SEM. *Significantly different from control within 
same age group (P < 0.05). aIndicates old sedentary control (OS) is significantly 
different from young sedentary control (YS) (P < 0.05). 
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However, there was no significant difference in pro-MMP-14 soluble protein levels 
between young sedentary controls and young trained rats (Fig. 16).    
 We also found similar results of pro-MMP-14 protein levels in the insoluble 
fraction of left ventricles (Fig. 17). Pro-MMP-14 insoluble protein levels in the left 
ventricle of old sedentary controls were significantly lower (-39.9%) than young 
sedentary controls. Exercise training significantly increased (+41.9%) pro-MMP-14 
insoluble protein levels in old exercise trained group compared to old sedentary controls 
(Fig. 17). But, exercise training had no effect on pro-MMP-14 insoluble protein levels of 
left ventricles in the young age group (Fig. 17).  
 
TIMP-1 protein levels 
 We found that protein levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) 
in the soluble fraction of left ventricles in the old rats were markedly higher (+123.0%) 
than young sedentary rats (Fig. 18). In contrast, exercise training significantly decreased 
TIMP-1 soluble protein levels by 50.8% in old trained rats compared to old sedentary 
rats (Fig. 18). However, there was no significant difference in TIMP-1 soluble protein 
levels between young sedentary rats and young trained rats (Fig. 18).    
 The proteins of TIMP-1 in the insoluble fraction of left ventricle tissues were not 
detectable in both young and old rats.  
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TIMP-2 protein levels 
There were no aging and exercise training effects on TIMP-2 protein levels in the 
soluble fraction of left ventricle tissues (Fig. 19). We just found reduced trend (P=0.263) 
in old trained groups compared to old sedentary controls (Fig. 19). In addition, the 
proteins of TIMP-2 in the insoluble fraction of left ventricles were undetectable in both 
young and old groups. 
 
TIMP-3 protein levels 
 We did not find the effects of aging and exercise training on TIMP-3 protein 
levels in the soluble fraction of left ventricles in both young and old groups (Fig. 20). 
Consistently, there were also no aging and exercise training effects on TIMP-3 protein 
levels in the insoluble fraction of left ventricles in both young and old groups (Fig. 21). 
  
TIMP-4 protein levels 
 In addition to TIMP-3 protein levels, there were no aging and exercise training 
effects on TIMP-4 protein levels in the soluble fraction of left ventricle tissues (Fig. 22). 
However, the protein levels of TIMP-4 in the insoluble fraction of old sedentary controls 
were significantly lower (-56.3%) compared to the young sedentary controls (Fig. 23). 
Exercise training had no significant effects on TIMP-4 protein levels in the old trained 
group compared to old sedentary controls (Fig. 23). In addition, there was no significant 
difference in TIMP-4 protein levels between young sedentary controls and young trained 
group (Fig. 23).    
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Fig. 18. Effect of aging and exercise training on TIMP-1 protein levels in the soluble 
fraction. Values are mean ± SEM. *Significantly different from control within same age 
group (P < 0.05). aIndicates old sedentary control (OS) is significantly different from 
young sedentary control (YS) (P < 0.05). 
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Fig. 19. Effect of aging and exercise training on TIMP-2 protein levels in the soluble 
fraction. Values are mean ± SEM.  
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Fig. 20. Effect of aging and exercise training on TIMP-3 protein levels in the soluble 
fraction. Values are mean ± SEM.  
 
 
 
 
 
 
 
 
            YS                 YE        OS                  OE 
50 kDa TIMP-3 
GAPDH 36 kDa 
0
50
100
150
YS YE OS OE
TI
M
P
-3
 s
ol
ub
le
 p
ro
te
in
 le
ve
ls
(%
 o
f c
on
tro
l)
 57
 
 
 
 
Fig. 21. Effect of aging and exercise training on TIMP-3 protein levels in the insoluble 
fraction. Values are mean ± SEM.  
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Fig. 22. Effect of aging and exercise training on TIMP-4 protein levels in the soluble 
fraction. Values are mean ± SEM.  
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Fig. 23. Effect of aging and exercise training on TIMP-4 protein levels in the insoluble 
fraction. Values are mean ± SEM. aIndicates old groups (OS, OE) are significantly 
different from young sedentary control (YS) (P < 0.05). 
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TNF-α levels 
 Left ventricle muscle levels of the inflammatory cytokine tumor necrosis factor-α 
(TNF-α) were not changed with aging (Fig. 24). However, 12 weeks of exercise training 
significantly reduced TNF-α levels by 19.4% compared with old sedentary control group 
(Fig. 24). No significant differences between young sedentary control and young 
exercise group were seen for TNF-α levels.  
 
TGF-β1 protein levels 
 The protein levels of transforming growth factor-β1 (TGF-β1) in the soluble 
fraction of the left ventricle in old sedentary controls were dramatically higher (+93.1%) 
than young sedentary controls (Fig. 25). Conversely, we found a significant decrease (-
23.5 %) in TGF-β1 protein levels with exercise training in the soluble fraction of left 
ventricle from old groups (Fig. 25). But, there was no significant training effect on TGF-
β1 protein levels in young groups (Fig. 25). The TGF-β1 proteins in the insoluble 
fraction of left ventricles were undetectable in both young and old groups.  
 
Myofibroblast (α-smooth muscle actin) 
 No changes in the protein levels of α-smooth muscle actin (α-SMA, 
myofibroblast marker) with aging and exercise training occurred in the soluble fraction 
of left ventricles (Fig. 26). The α-SMA proteins in the insoluble fraction of left ventricles 
were undetectable in both young and old groups.  
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Fig. 24. Effect of aging and exercise training on TNF-α levels in the soluble fraction. 
Values are mean ± SEM. *Significantly different from control within same age group (P 
< 0.05).  
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Fig. 25. Effect of aging and exercise training on TGF-β1 protein levels in the soluble 
fraction. Values are mean ± SEM. *Significantly different from control within same age 
group (P < 0.05). aIndicates old sedentary control (OS) is significantly different from 
young sedentary control (YS) (P < 0.05). 
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Fig. 26. Effect of aging and exercise training on α-SMA (myofibroblast marker) protein 
levels in the soluble fraction. Values are mean ± SEM.  
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CHAPTER IV 
DISCUSSION 
 
The major and novel findings of the current study include the following 
observations. Regular endurance exercise training ameliorated the age-induced increase 
in extramyocyte space of the left ventricle. We demonstrated exercise training might 
protect against age-induced fibrosis by increasing MMP-2, MMP-14 in the soluble 
fraction and MMP-1, MMP-3, MMP-14 in the insoluble fraction of old rat heart. 
Conversely, exercise training might reduce the fibrosis by decreasing TIMP-1 in the 
soluble fraction of old rat heart. Endurance exercise training reduced upstream pro-
fibrotic mediators including TNF-α and TGF-β1 in the aging rat heart, while no 
changing α-smooth muscle actin as a myofibroblast marker. To our knowledge, these are 
the first data to indicate that exercise training has a protective effect against age-induced 
extracellular collagen matrix remodeling in the aging heart, associated with MMPs, 
TIMP-1, TNF-α, and TGF-β1 expression that was more similar to young hearts.   
 
Left ventricle morphology 
Long-term endurance exercise training reduced age-induced accumulation of 
extramyocyte space (Fig. 3) and collagen contents (Fig. 4) in the heart. Increased 
extramyocyte space with aging may be caused by increased extracellular matrix 
including collagens, increased fat, and increased fluid volume in the heart. Our findings 
are consistent with previous studies (19, 35, 54, 76, 85, 124, 125, 135). Taken together, 
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the increased collagens might be an integral part of extracellular matrix remodeling that 
takes place in the left ventricle consequent to the natural aging process leading to an 
increase in myocardial passive stiffness and impaired contractile function.            
Our findings provide a theoretical paradigm by which endurance exercise can 
ameliorate progressive impairment of function in the aging heart. Preservation of 
myocyte number and reduced fibrosis may increase the capacity to pump blood while 
reducing internal work (57). Endurance training has also been documented to protect 
against reduced left ventricle filling during diastole (43). Changes in early ventricular 
filling are a marker of altered material properties of the left ventricle (43). Increased 
filling and enhanced systolic function that result from exercise training in the aging 
human heart suggest improved Ca2+ handling and protection against i) reduced elasticity, 
ii) increased stiffness, and iii) elevated internal work. Such observations in human 
patients are consistent with amelioration of fibrosis and ventricular remodeling in the left 
ventricles of exercise-trained aging rats as indicated in Fig. 2 and Fig. 4. Centurione et 
al. (25) postulated that reduction in myocyte number and increased fibrosis contributed 
to impaired diastolic filling rate. Indeed, amelioration of age-related changes in myocyte 
number, size, and connective tissue by exercise training could help to explain exercise-
induced protection of diastolic and ventricular function in the aging heart noted in 
clinical studies (43, 68).   
The mechanical relationship between the cardiac myocytes and extracellular 
collagen matrix is complex and interactive. Collagens are a regulated family of proteins 
that provide the structure and optimize the function of the heart (8). A healthy 
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arrangement of collagens provides a framework for myocyte sheath sliding, 
transmittance of force from myocyte to the ventricular chamber, prevents excessive 
stretch and damage, and preserves heart function (37), which is essential for efficient 
cardiac function. However, excessive accumulation of collagen matrix called fibrosis 
with aging results in elevated myocardial stiffness and cardiac dysfunction (8, 30). 
Aging increases the rate of ventricular collagen turnover and deposition by fibroblasts 
with aging (8, 124, 125).  Fibrosis with aging is characterized by increased collagen 
content (35, 54), decreased collagen solubility, and increased collagen cross-linking 
(124, 125). This increase in collagen deposition during aging may be thought to result 
from a combination of cellular events including increased collagen synthesis and 
decreased collagen degradation. The collagen might become more resistant to 
collagenase degradation with aging (59).  
Aging not only clearly increased the amount of connective tissue but also altered 
the geometry (Fig. 4), being ingredients for a dysfunctional mechanical environment. 
This occurred primarily in the left ventricle toward the endocardial surface in the current 
study, which could most affect diastolic filling and wall motion (62). Remarkably, 
amelioration of age-induced remodeling by 12 weeks of endurance exercise training was 
not simply a reduction in the area of the left ventricle occupied by collagen connective 
tissue, but importantly a more normal, linear geometric pattern (Fig. 2. Fig. 4).  Sheaths 
of myocardial cells with exercise training in old heart appeared largely preserved, 
dissimilar to the discontinuous and more random pattern of connective tissue exhibited 
in the left ventricles of old, sedentary animals.  Although untested in the current study, 
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better retention of normal geometry by regular exercise could ameliorate internal 
ventricular work of the aging heart. In addition, Thomas et al (124, 125) observed that 
ten weeks of treadmill exercise training modulated age-induced upregulation of collagen 
cross-linking (HP) in the left ventricle of rats.      
  
Effects of aging and exercise training on MMPs and TIMPs 
Cardiac ECM plays an important role in cardiac structure and function. In 
particular, accumulation of cardiac collagens with aging could result in diminished 
systolic performance, decreased compliance, and diastolic dysfunction (37). The 
collagen ECM depends on a balance between matrix metalloproteinases (MMPs) and 
tissue inhibitors of metalloproteinases (TIMPs), which determines cardiac remodeling 
(1, 59). MMPs are an endogenous family of enzymes that degrade ECM proteins, which 
are responsible for ECM remodeling in a number of physiological and pathological 
process (1, 127).  
Most of MMPs are inactive, secreted enzymes that are stimulated extracelluarly 
after activation. However, some membrane-type MMPs are anchored to the cell 
membrane (60). It has been shown that important MMPs highly related with myocardial 
remodeling are collagenases (e.g., MMP-1 and MMP-13), gelatinases (e.g., MMP-2 and 
MMP-9), stromelysin (e.g., MMP-3), and the membrane-type MMP (e.g., MMP-14) 
(63). In contrast, MMPs are regulated by endogenous inhibitors, TIMPs (59). TIMPs are 
specific MMP inhibitors in the ECM (78). The role of TIMPs is to prevent excessive 
ECM degradation by MMPs. 
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Effect of aging 
We found differential responses of MMPs to aging in the left ventricles. Contrary 
to the hypothesis that aging would result in the elevation of MMPs in the left ventricles, 
aging decreased protein levels of pro-MMP-2 (Fig. 9), active MMP-2 (Fig. 11), pro-
MMP-14 (Fig. 16) in the soluble fraction and active MMP-1 (Fig. 8), pro-MMP-14 (Fig.  
17) in the insoluble fraction of left ventricles, while no changes with aging in pro/active 
MMP-1 (Fig. 5, Fig. 7), pro-MMP-9 (Fig. 14) in the soluble fraction and pro-MMP-1 
(Fig. 6), pro-MMP-2 (Fig. 10), pro-MMP-3 (Fig. 13), pro-MMP-9 (Fig. 15) in the 
insoluble fraction. But, overall effects of aging on MMPs in the current study were 
reduced protein levels of MMPs in the left ventricle, indicating that the depression of the 
degradation by MMPs is in part responsible for age-associated fibrosis.  
There were controversial results regarding effect of aging on MMPs in the heart. 
Lindsey et al. (76) indicated that the levels of MMP-3, MMP-8, MMP-9, MMP-12, and 
MMP-14 increased in the insoluble fraction of old mouse heart, compared to young 
group. However, Robert et al. (98) showed that there were 40-45% decreases of both 
MMP-2 and pro-MMP-1 activity and mRNA in 24-month-old rat heart compared to 
young groups. The current data appear to rectify some of the contradictory findings of 
previous investigations. However, discrepancies between current study and previous data 
from Lindsey et al. (76) may be due to differences in dissection, protein extraction, 
species, and aging of animals. For example, we used Fischer 344×Brown Norway F1 
hybrid rats (34 mon for old rats) as opposed to the CB6F1 mice (23 mon for old mice).  
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Interestingly, in contrast to other MMPs, aging led to a significant elevation of 
pro-MMP-3 protein levels in the soluble fraction of left ventricle (Fig. 12). Although 
age-induced increase in pro-MMP-3 levels was not directly associated with cardiac 
fibrosis, this finding may suggest that aging is presumably associated with increased 
ECM degradative capacity as well.       
In addition to MMPs, we also found differential responses of TIMPs to aging in 
the left ventricles. Aging increased the protein levels of TIMP-1 (Fig. 18) in the soluble 
fraction and decreased TIMP-4 protein levels (Fig. 23) in the insoluble fraction of left 
ventricles. Increased TIMP-1 in the soluble fraction with aging might be associated with 
age-induced cardiac fibrosis, whereas decreased TIMP-4 in the insoluble fraction with 
aging would support the additional degradation of ECM proteins. Taken together, the 
regulation of MMPs and TIMPs is implicated in ECM remodeling with aging. The 
overall decrease of MMPs in both fractions and increased TIMP-1 in soluble fraction 
potentially might promote the accumulation of ECM proteins including collagens with 
advancing age. 
Proteins found in the soluble fraction include cytoplasmic proteins and soluble 
ECM proteins, while proteins found in the insoluble fraction contain membrane proteins 
and insoluble ECM proteins (63). The fact that TIMP-1 and TIMP-2 known soluble 
proteins were only detected in the soluble fraction in the current study verifies this idea.  
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Effect of exercise training 
We found that exercise training increased protein levels of active MMP-2 (Fig. 
11), pro-MMP-14 (Fig. 16) in the soluble fraction and active MMP-1 (Fig. 8), pro-
MMP-3 (Fig. 13), pro-MMP-14 (Fig. 17) in the insoluble fraction in the aging left 
ventricles. Overall effects of exercise training on MMPs in the current study were to 
elevate protein levels of MMPs in the aging left ventricles, suggesting that the 
degradation by MMPs is in part responsible for exercise training-induced protection 
against cardiac fibrosis. These data are consistent with the hypothesis that exercise 
training would attenuate age-induced alterations in MMPs in the aging heart.    
The exercise training effects on MMP protein levels take place in the only old rat 
groups except soluble pro-MMP2, which was reduced by exercise training in the young 
rat groups. Although the efficacy of exercise training regimen is effective in the young 
group including increased heart-to-body weight ratio and citrate synthase activity of 
soleus skeletal muscle with the exercise training (Table 1), the exercise training effects 
on MMP protein levels in the young groups were minimal. These results were confirmed 
by other studies (38, 68).  
In addition, protection of left ventricle morphology and MMP changes in the old 
rat hearts by exercise training did not appear to be related to changes in oxidative 
capacity in skeletal muscle. While citrate synthase activity was significantly reduced 
with age, exercise training surprisingly had little positive benefit on citrate synthase 
activity in the old skeletal muscle rats (Table 1). The lack of an exercise effect for citrate 
synthase in soleus muscle of old groups may be indicative of relatively low exercise 
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intensity in the current study. However, based on the training experience in the current 
study, the exercise performance of old rats groups was almost maximum because they 
are too heavy and fat compared to young groups. We can also predict that the skeletal 
muscle of old rats might be degradative even though they exercised.                   
It is also extremely interesting that exercise training resulted in a marked 
reduction of only TIMP-1 soluble protein levels in the aging heart (Fig. 18). The 
attenuation of TIMP-1 in the soluble fraction by exercise training potentially may protect 
against fibrosis in the aging heart. These results from current study provide the 
foundation for future intervention studies that TIMP-1 inhibition with exercise training 
might ameliorate age-induced fibrosis much more in the heart. Taken together, exercise 
training protects against age-related fibrosis or connective tissue accumulation by the 
upregulation of pro- or active MMP-1, -2, -3, -14 in the soluble or insoluble fractions 
and by the downregulation of TIMP-1 in the soluble fraction. 
 
Effects of aging and exercise training on potential upstream mediators 
Tumor necrosis factor-alpha (TNF-α) 
TNF-α has a variety of biological functions in response to the changes in 
environmental stress in the heart, suggesting that TNF-α might be involved in alterations 
in cardiac myocytes and extracellular matrix (81). In particular, it seems like that TNF-α 
may lead to an imbalance in myocardial MMP/TIMP ratio as a potential upstream 
mediator of MMPs and TIMPs, resulting in altered myocardial ECM structure and LV 
dysfunction (59, 118). We found that TNF-α activity levels did not change with age in 
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the left ventricle (Fig. 24), which is consistent with previous studies (103, 105), even 
though there are conflicting evidences that TNF-α is associated with aging (21, 34, 104). 
In contrast, exercise training decreased the levels of TNF-α activity in the aging left 
ventricles in the current study (Fig. 24) as other studies (7, 10, 71, 72), indicating 
exercise training-induced suppression of TNF-α.  
The downregulation of TNF-α activity with exercise training in old rats might be 
associated with elevated levels of insoluble active MMP-1, soluble active MMP-2, 
insoluble pro-MMP-3, and soluble/insoluble pro-MMP-14, and reduced levels of soluble 
TIMP-1 with exercise training in the old rats in the current study. We postulate that 
TNF-α may presumably stimulate extracellular collagen matrix synthesis by 
downregulating MMPs and upregulating TIMP-1. These findings are consistent with 
previous data. For example, Sivasubramanian et al. (116) reported that there were 
significant decrease in total MMP activity and increase in TIMP-1 levels in the cardiac 
overexpression of TNF-α in transgenic mice, suggesting a possible mechanism for the 
increase in myocardial fibrosis.     
In contrast, there are controversial reports that TNF-α could increase the 
extracellular collagen matrix degradation by upregulating MMPs and downregulating 
TIMPs (59, 74, 118). For example, Li et al. (74) reported that cardiac overexpression of 
TNF-α in transgenic mice resulted in the elevation in MMP-2 and MMP-9 activity as 
well as marked diastolic dysfunction. In the cardiac fibroblasts, TNF-α reduces collagen 
synthesis, increases MMP expression, and decreases TIMP expression (75, 117). Taken 
together, although the mechanisms are not fully understood, the imbalance in 
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MMP/TIMP ratio in the heart would be ameliorated by exercise training-induced 
downregulation of TNF-α in the aging rat hearts. 
 
Transforming growth factor-beta1 (TGF-β1) 
We found that aging increased TGF-β1 protein levels in the left ventricle (Fig. 
25). These findings are consistent with the hypothesis that aging results in the 
upregulation of TGF-β1 leading to the fibrosis in the heart. TGF-β consists of three 
isoforms, TGF-β1, TGF-β2, and TGF-β3 that are structurally and functionally closely 
related to one another (2). The TGF-β, an anti-inflammatory cytokine, is a potent 
stimulator of collagen synthesis (112, 118). It mediates collagen synthesis via reduced 
MMPs or enhanced TIMPs, thus favoring an accumulation of ECM (12, 118).  
TGF-β may play an important role in stimulating abnormal accumulation of 
ECM proteins including collagens in the cardiovascular diseases. Rosenkranz et al. (100) 
showed that TGF-β overexpression in the transgenic mice heart resulted in cardiac 
hypertrophy and fibrosis. Similarly, Brooks & Conrad (15) found that TGF-β1 deficient 
old mice heart exhibited a decrease in myocardial fibrosis and reduced myocardial 
stiffness, indicating the role of TGF-β to contribute to ECM component synthesis in the 
heart.   
In contrast, exercise training resulted in a marked reduction of TGF-β1 protein 
levels in the left ventricle from old rats (Fig. 25).To our knowledge the current study is 
the first to demonstrate that TGF-β1 protein levels are reduced in the left ventricle as a 
result of prolonged exercise training. The responses of TGF-β1 with exercise training in 
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old rat hearts might be associated with the changes in MMPs and TIMP-1 levels, 
indicating that TGF-β is an upstream regulator of MMPs and TIMPs leading to cardiac 
fibrosis. Taken together, exercise training ameliorates age-induced cardiac fibrosis by 
downregulating an upstream regulator, TGF-β1.       
 
Alpha-smooth muscle actin (myofibroblast marker) 
Myofibroblast is a differentiated cell type from fibroblast characterized by 
increased ECM protein synthesis especially collagen type I, providing an essential role 
for ECM remodeling during normal and pathological wound healing (30, 96, 126, 129). 
Myofibroblast expression may be not detectable in the normal healthy adult hearts, while 
myofibroblasts are often associated with injured heart such as myocardial infarction for 
wound healing (8, 94, 133). In particular, the expression of α-smooth muscle actin (α-
SMA) is considered to be the most reliable marker of differentiated myofibroblasts (28, 
96, 113).  
We found that there were no significant effects of aging and exercise training on 
alpha-smooth muscle actin (α-SMA) as a myofibroblast marker in the current study (Fig. 
26). Contrary to our expectation, α-SMA did not follow a pattern reflective of changes in 
TGF-β1 with aging and exercise training. These data are inconsistent with the hypothesis 
that alterations in myofibroblasts with aging and exercise training are exclusively 
downstream of the TGF-β (28, 36). Taken together, the current study indicated that the 
α-SMA levels are delinked with TGF-β1 with aging and exercise training in the left 
ventricles.  
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However, current data on α-SMA with exercise training were confirmed by a 
previous study (57). The results indicated that there was no change of mRNA levels of 
α-smooth muscle actin in the young (6-8 wk) rat heart after13 week treadmill exercise 
training.  
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
 
This dissertation provides a comprehensive analysis of the effects of exercise 
training on extracellular matrix and remodeling in the aging rat left ventricles. The 
purpose of this study was to (a) to determine whether aging affects extracellular matrix 
remodeling, and (b) to identify the effects of exercise training on age-induced changes in 
extracellular matrix remodeling in the heart. The results of the present study 
demonstrated that cardiac fibrosis with aging was associated with decreased soluble 
MMP-2, MMP-14 and insoluble MMP-1, MMP-3, MMP-14, and increased soluble 
TIMP-1 and TGF-β1. However, 12 weeks of endurance exercise training might reverse 
the age-induced changes in extracellular matrix remodeling-related factors in the heart. 
These novel findings indicate protective and reversible effects of exercise training 
against fibrosis and extracellular matrix remodeling in the aging heart. 
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